Last Price$37.29.3%
Market Cap$3,309.7M
123.0%
Industry median - 13.4%
5Y Historical average - 99.0%
N/A
Industry median - 0.3%
5Y Historical average - 377.6%
(59.1%)
Industry median - (20.6%)
5Y Historical average - 111.3%
(44.5%)
Industry median - (1.7%)
5Y Historical average - 91.7%
LEGN Growth Rating
LEGN Growth rating
7.5
LEGN Growth rating performance
LEGN Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with LEGN Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$3,309.7M | 7.5 | 68.9% | 123.0% | 116.3% | 12.2% | (59.1%) | (70.7%) | 37.4% | (44.5%) | |
$124.8B | 6.9 | 21.5% | 11.5% | 8.6% | N/A | N/A | (962.4%) | N/A | N/A | |
$77.0B | 5.6 | 12.6% | 8.3% | 2.4% | 16.1% | 10.3% | 3.1% | 12.5% | (5.7%) | |
$34.4B | 6.3 | 106.9% | 127.3% | 76.3% | (9.7%) | (57.5%) | (132.2%) | N/A | (70.8%) | |
$30.7B | 5.4 | 59.2% | 23.0% | 28.6% | (23.2%) | (38.5%) | (26.5%) | (36.7%) | N/A | |
$24.0B | 6.2 | 90.9% | (28.0%) | (28.0%) | 36.5% | N/A | (182.9%) | (3.1%) | N/A | |
$14.5B | 4.0 | 4.5% | (3.8%) | 35.4% | (19.0%) | (9.0%) | 144.6% | 10.7% | (7.3%) | |
$13.8B | 7.5 | 14.7% | 23.6% | 9.1% | N/A | 25.6% | 6.8% | N/A | 44.5% | |
$13.4B | 7.1 | 10.8% | 17.8% | 10.0% | N/A | 152.8% | 48.9% | N/A | 820.5% | |
$13.3B | 6.1 | (100.0%) | N/A | N/A | (0.9%) | (92.8%) | 11.4% | 44.6% | 84.8% | |
$1,846.9M | 5.9 | 50.5% | 50.5% | 50.7% | 25.3% | 20.9% | (35.6%) | 3.3% | (43.8%) |
FAQ
What is the Legend Biotech Corporation (LEGN) revenue growth?
The Legend Biotech Corporation (LEGN) revenue growth is 123.0%, which is lower than the industry median of 13.4% and the 5-year historical average of 99.0%.
What is the Legend Biotech Corporation (LEGN) operating income growth?
The Legend Biotech Corporation (LEGN) operating income growth is N/A, compared to the industry median of 0.3% and the 5-year historical average of 377.6%.
What is the Legend Biotech Corporation (LEGN) EPS (Earnings Per Share) growth?
The Legend Biotech Corporation (LEGN) EPS growth is (59.1%), compared to the industry median of (20.6%) and the 5-year historical average of 111.3%.
What is the Legend Biotech Corporation (LEGN) Free Cash Flow (FCF) growth?
The Legend Biotech Corporation (LEGN) Free Cash Flow growth is (44.5%), compared to the industry median of (1.7%) and the 5-year historical average of 91.7%.